News Release

Selected 140th in the ranking of Financial Times High-Growth Companies Asia-Pacific 2020

• Notice of land acquisition by Beijing Continent Pharmaceutical Co., Ltd.
• A study to evaluate the efficacy and safety of Pirfenidone for the novel Coronavirus infection 2